PHARMACEUTICAL & BIOTECHNOLOGY
Uni LifeScience is developing pharmaceutical and biotechnology solutions. Our focus is on building a responsible foundation for future progress, with clear distinctions between development priorities, evidence, and confirmed availability.
In preparation / development
Our earlier website identified injectable and tablet semaglutide as an initial area of focus. This is a previously stated development priority, not a current product offer. Product availability, formulation details, development milestones, and applicable regulatory status have not been confirmed for this website.
Our stated quality ambitions reference GMP, ISO, and COFEPRIS requirements. These are goals to be evaluated against the requirements that apply to each activity. They are not claims that Uni LifeScience holds a certification, authorization, or approved manufacturing capability.
As specific programs are confirmed, this section can explain their purpose, stage, supporting evidence, and regulatory context. Scientific and commercial inquiries are welcome through our general contact channel. No medicine is offered for purchase or prescribed through this website.
